Harold E Selick Protagonist Therapeutics, Inc (PTGX) insider trading activity

PTGX Quotes by TradingView

Harold E Selick is Director of Protagonist Therapeutics, Inc. Currently has a direct ownership of 46,546 shares of PTGX, which is worth approximately $3.94 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 2,695 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.5K
6.15% 3M change
40.51% 12M change
Total Value Held $3.94 Million

HAROLD E SELICK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
-
2,695 Added 5.47%
46,546 Common Stock
Apr 28 2025
BUY
Exercise of conversion of derivative security
$12,441 $1.16 p/Share
10,725 Added 19.65%
43,851 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
5,130 Added 13.41%
33,126 Common Stock
Mar 07 2024
BUY
Exercise of conversion of derivative security
$12,266 $1.89 p/Share
6,490 Added 18.82%
27,996 Common Stock
Apr 10 2023
BUY
Exercise of conversion of derivative security
$5,390 $0.87 p/Share
6,196 Added 22.37%
21,506 Common Stock

Also insider at

MTEM
Molecular Templates, Inc. Healthcare
HES

Harold E Selick

Director
Newark, CA

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTGX